| Bioactivity | (Rac)-NMDAR antagonist 1 is the racemate of NMDAR antagonist 1. NMDAR antagonist 1 is a potent and orally bioavailable NR2B-selective NMDAR antagonist[1]. | ||||||||||||
| Target | NMDAR | ||||||||||||
| Name | (Rac)-NMDAR antagonist 1 | ||||||||||||
| CAS | 2435557-99-4 | ||||||||||||
| Formula | C20H20BrN3O2 | ||||||||||||
| Molar Mass | 414.30 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Zhang L, et al. Design, synthesis and bioevaluation of 1,2,3,9-tetrahydropyrrolo[2,1-b]quinazoline-1-carboxylic acid derivatives as potent neuroprotective agents. Eur J Med Chem. 2018 May 10;151:27-38. |